As part of Malnutrition Awareness Week, it was recommended that more physicians are seeing individuals who are taking GLP-1 drugs providing with this problem.
Speaking on the findings with Newstalk Breakfast was Sandra Wilkinson, signed up dietitian and Communications Manager at the Irish Nutrition & & Dietetic Institute, who exposed the stunning figures behind the claims.
She stated: “We have some research study from Ireland that was performed rather just recently, back in 2023, and it took a look at all clients who were confessed to medical facility in Ireland in a study from a variety of various healthcare facilities.
“It revealed that, really, 65% of those clients who were at threat of poor nutrition really weren’t underweight.
“I believe in Ireland, when individuals think about poor nutrition, they tend to consider hunger, which is triggered simply by an absence of access to food, for instance, throughout a starvation or possibly associated to food hardship or conditions like anorexia.
“We don’t tend to think of those patients who might physically look quite a normal size or even in some cases they might have an excess body weight or be overweight.”
The main point to consider with concerns to malnourishment is it’s not simply a decrease in fat, however of muscle too.
She continued: “The effect of weight-loss in clients, and of poor nutrition clients, is extremely typically associated to an absence of muscle since muscle functions as a reserve and a sufficient protein consumption in the diet plan assists to safeguard that muscle reserve.
“Often when individuals do slim down, there might be some loss of muscle, however preserving that, reducing the quantity of muscle that’s lost is extremely essential.
“So I suppose, oftentimes, when patients are on GLP-1s, it is important to assess muscle function.”
Main image: Semaglutide drugs Wegovy and Ozempic. Photo: Alamy
Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND
Subscribe to get the latest posts sent to your email.





